microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients-Reference-Cited by-同舟云学术

microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients

Published:2018-09 Issue:3 Volume:155 Page:784-798
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Mari Luigi,Hoefnagel Sanne J.M.,Zito Domenico,van de Meent Marian,van Endert Peter^ORCID,Calpe Silvia^ORCID,Sancho Serra Maria del Carmen,Heemskerk Mirjam H.M.,van Laarhoven Hanneke W.M.,Hulshof Maarten C.C.M.,Gisbertz Susanne S.,Medema Jan Paul,van Berge Henegouwen Mark I.,Meijer Sybren L.,Bergman Jacques J.G.H.M.,Milano Francesca,Krishnadath Kausilia K.

Funder

EAC

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

2. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma;Ribas;JAMA,2016

3. Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475);Doi;J Clin Oncol,2016

4. Safety, PD-L1 expression, and clinical activity of avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced gastric or gastroesophageal junction cancer;Chung;J Clin Oncol,2016

5. Pembrolizumab (MK-3475) for previously treated metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: Phase II KEYNOTE-180 study;Shah;J Clin Oncol,2016

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non‐canonical RNA‐binding protein ANXA11 regulates microRNA resorting into small extracellular vesicles to mediate cisplatin resistance;The FASEB Journal;2024-09

2. Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy;Journal for ImmunoTherapy of Cancer;2024-08

3. Identification of RNA-binding protein hnRNP C targeting the 3’UTR of the TAP-associated glycoprotein tapasin in melanoma;OncoImmunology;2024-06-27

4. Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion;Biology;2024-04-28

5. Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer;World Journal of Gastroenterology;2024-04-28